A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers

Clinical trial NCT05509153 · RECRUITING

Trial details

NCT number: NCT05509153
Sponsor: Western Sydney Local Health District
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2024-06-01
Primary completion: 2026-11-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.